Author

Tugba Ozturk

Emory UniversityORCID 0000-0003-1083-0684Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:clinical cohort / trial· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Bikash BogatiiD· 1 shared David S. WeissiD· 1 shared Sarah W. SatolaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Bikash BogatiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintMar 5, 2025

Sulbactam-durlobactam susceptibility among cefiderocol heteroresistant Acinetobacter

Bikash Bogati, Tugba Ozturk, Sarah W. Satola, David S. Weiss

The paper tests sulbactam-durlobactam susceptibility in cefiderocol heteroresistant Acinetobacter isolates and finds no heteroresistance, supporting its efficacy and potential prioritization over cefiderocol.

DOI 10.1101/2025.03.05.641507

humanclinical cohort / trial

𝕏 PostBluesky